This smaller version is ideal for very low doses (0.1 to 0.3 ml) and allows even finer IU markings
BPC-157 is a synthetic 15-amino acid peptide fragment derived from human gastric juice protein, available as a lyophilized powder for laboratory research
Understanding Dull Pain: What Is It
The best time to inject is 30 to 45 minutes before bedtime, on an empty stomach, ideally 2 to 3 hours after your last meal
Stack protocol: BPC-157: 250 to 500 mcg subcutaneous, once or twice a day Inject near the injury when you can reach it TB-500: 2 to 2.5 mg subcutaneous, twice a week (loading phase) Inject away from the injury, lower abdomen or outer thigh works fine 2 mg once a week (maintenance phase) Both run at the same time through the loading phase
Cagrilintide and semaglutide work through different mechanisms and have different dosing schedules: Cagrilintide: Amylin receptor agonist Escalation: 0.6 mg 1.2 mg 2.4 mg weekly Three-step titration over 8 weeks Semaglutide: GLP-1 receptor agonist Escalation: 0.25 mg 0.5 mg 1.0 mg 1.7 mg 2.4 mg weekly Five-step titration over 16-20 weeks When combined in CagriSema, both peptides are dosed at 2.4 mg weekly, representing the maximum studied dose for each component